A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries

The growing burden of cancer among several major noncommunicable diseases (NCDs) requires national implementation of tailored public health surveillance. For many emerging economies where emphasis has traditionally been placed on the surveillance of communicable diseases, it is critical to understand the specificities of NCD surveillance and, within it, of cancer surveillance. We propose a general framework for cancer surveillance that permits monitoring the core components of cancer control. We examine communalities in approaches to the surveillance of other major NCDs as well as communicable diseases, illustrating key differences in the function, coverage, and reporting in each system. Although risk factor surveys and vital statistics registration are the foundation of surveillance of NCDs, population-based cancer registries play a unique fundamental role specific to cancer surveillance, providing indicators of population-based incidence and survival. With an onus now placed on governments to collect these data as part of the monitoring of NCD targets, the integration of cancer registries into existing and future NCD surveillance strategies is a vital requirement in all countries worldwide. The Global Initiative for Cancer Registry Development, endorsed by the World Health Organization, provides a means to enhance cancer surveillance capacity in low- and middle-income countries.

[1]  D. Parkin,et al.  The role of cancer registries in cancer control , 2008, International Journal of Clinical Oncology.

[2]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[3]  Melanie J. Cowan,et al.  The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. , 2016, American journal of public health.

[4]  Jie He,et al.  Annual report on status of cancer in China, 2011. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[5]  F. Bray,et al.  The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control , 2015 .

[6]  D. West,et al.  Cancer Surveillance Research: a Vital Subdiscipline of Cancer Epidemiology , 2005, Cancer Causes & Control.

[7]  S. Rosso,et al.  Completeness and timeliness: Cancer registries could/should improve their performance. , 2015, European journal of cancer.

[8]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[9]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. , 2009, European journal of cancer.

[10]  S. Scoppa,et al.  Two Suspected Worksite or Occupational Cancer Clusters Investigated Using the Cancer Data Registry and Multiple Primary Standardized Incidence Ratios in SEER *Stat-Idaho, 2013-2014. , 2016, Journal of registry management.

[11]  Jacques Ferlay,et al.  The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis Web appendix section , 2012 .

[12]  P. Vineis,et al.  Global cancer patterns: causes and prevention , 2014, The Lancet.

[13]  E. Törnvall,et al.  Swedish diabetes register, a tool for quality development in primary health care , 2012, Primary Health Care Research & Development.

[14]  Hutcha Sriplung,et al.  Cancer survival in Africa, Asia, and Central America: a population-based study. , 2010, The Lancet. Oncology.

[15]  E. Jo,et al.  Development of a Virtual Diabetes Register using Information Technology in New Zealand , 2015, Healthcare informatics research.

[16]  P. Remington,et al.  Communicating Public Health Surveillance Information for Action , 2010 .

[17]  Richard J. K. Taylor,et al.  Erroneous inflation of diabetes prevalence: Are there global implications? , 2016, Journal of diabetes.

[18]  O. M. Jensen,et al.  Cancer Registration: Principles and Methods , 1991 .

[19]  P. Ruff,et al.  Establishment of a cancer surveillance programme: the South African experience. , 2015, The Lancet. Oncology.

[20]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[21]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[22]  U. Gerdtham,et al.  Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden , 2014, International journal of environmental research and public health.

[23]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[24]  Ruth Bonita,et al.  Capacity building for an integrated noncommunicable disease risk factor surveillance system in developing countries. , 2003, Ethnicity & disease.

[25]  S. Merajver,et al.  Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. , 2013, Journal of registry management.

[26]  Per Gustavsson,et al.  Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies , 2012, International journal of cancer.

[27]  C. Poole A history of the population attributable fraction and related measures. , 2015, Annals of epidemiology.

[28]  F. Berrino,et al.  Interpreting Survival Differences and Trends , 1997, Tumori.

[29]  B. Armstrong The role of the cancer registry in cancer control , 1992, Cancer Causes & Control.

[30]  Samira Asma,et al.  Evolution of the Global Tobacco Surveillance System (GTSS) 1998–2008 , 2009, Global health promotion.

[31]  I. Gropp [International trends in social care]. , 1980, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete.

[32]  Lisa M. Lee,et al.  Principles & Practice of Public Health Surveillance , 2010 .

[33]  P. Dickman,et al.  Interpreting trends in cancer patient survival , 2006, Journal of internal medicine.

[34]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. , 2009, European journal of cancer.

[35]  R. Mckeown,et al.  The Epidemiologic Transition: Changing Patterns of Mortality and Population Dynamics , 2009, American journal of lifestyle medicine.

[36]  C. Mathers,et al.  Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.

[37]  C. Ulrich,et al.  Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally , 2014, Journal of the National Cancer Institute.

[38]  S. Eser,et al.  Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[39]  W. Blattner,et al.  Developing National Cancer Registration in Developing Countries – Case Study of the Nigerian National System of Cancer Registries , 2015, Front. Public Health.

[40]  A. Keys CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[41]  S. Dowell,et al.  Surveillance in Low-Resource Settings: Challenges and Opportunities in the Current Context of Global Health , 2010 .

[42]  A. Nahvijou,et al.  Challenges to promoting population-based cancer registration in Iran: a workshop report. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[43]  P. Byass,et al.  The development and experience of epidemiological transition theory over four decades: a systematic review , 2014, Global health action.

[44]  P. Giorgi Rossi,et al.  Building a population-based diabetes register: an Italian experience. , 2014, Diabetes research and clinical practice.

[45]  M. Thun,et al.  A national framework for cancer surveillance in the United States , 2005, Cancer Causes & Control.

[46]  J. Caldwell Population health in transition. , 2001, Bulletin of the World Health Organization.

[47]  M. Piñeros,et al.  Discrepancies in the handling of cancer data in Colombia , 2016 .

[48]  F. Shaw,et al.  A history of MMWR. , 2011, MMWR supplements.

[49]  F. Bray,et al.  International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.

[50]  Cours Albert-Thomas Relative Value of Incidence and Mortality Data in Cancer Research , 1989 .

[51]  M. Coleman,et al.  Cancer incidence, survival and mortality: Explaining the concepts , 2014, International journal of cancer.

[52]  P. Eastman Annual Report on Status of Cancer from ACS, NCI, CDC, Cancer Registries: Targeted Focus on Latinos Will Likely Improve US Cancer Rates , 2006 .

[53]  M. Bloomberg,et al.  Understanding death, extending life , 2015, The Lancet.

[54]  J. Ferlay,et al.  International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. , 2014, Lung cancer.

[55]  Nathan Nunn,et al.  Historical Development , 2013 .

[56]  P. Jha Reliable direct measurement of causes of death in low- and middle-income countries , 2014, BMC Medicine.

[57]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[58]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[59]  Steven M. Teutsch,et al.  Considerations in Planning a Surveillance System , 2010 .

[60]  A. Keys Coronary heart disease in seven countries. 1970. , 1997, Nutrition.

[61]  R. Sankaranarayanan Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction. , 2000, IARC scientific publications.

[62]  S. Novello,et al.  Lung cancer in never smokers: a different disease , 2014, Current Respiratory Care Reports.

[63]  K. Straif,et al.  Cancer in the 25×25 non-communicable disease targets , 2014, The Lancet.

[64]  P. Zimmet,et al.  Diabetes mellitus statistics on prevalence and mortality: facts and fallacies , 2016, Nature Reviews Endocrinology.

[65]  C. Mathers,et al.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer , 2012, BMC Medical Research Methodology.

[66]  S. Mendis The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective. , 2010, Progress in cardiovascular diseases.

[67]  A. Sié,et al.  Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. , 2014, Global health action.

[68]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[69]  F. Bray,et al.  PLANNING AND DEVELOPING POPULATION-BASED CANCER REGISTRATION IN LOW-AND MIDDLE-INCOME SETTINGS , 2014 .

[70]  L. Bravo,et al.  Comprehensive assessment of population-based cancer registries: an experience in Colombia. , 2014, Journal of registry management.